Does isolated IgG reactivity to these pathogens usually mean prior exposure?

Isolated IgG seroreactivity is a common source of overdiagnosis when interpreted without symptoms, timing, and pathogen-directed confirmatory testing. Across these infections, IgG primarily documents immune recognition and usually cannot distinguish remote exposure from current disease.

Clinical interpretation

• For Babesia microti, antibodies may remain detectable for at least a year after clearance. IDSA recommends confirming a positive antibody result by peripheral-blood smear or PCR before treatment decisions.
• For Chlamydia pneumoniae and Mycoplasma pneumoniae, a single IgG result should not be used to diagnose acute respiratory infection. Respiratory NAAT/PCR is preferred when acute infection is suspected.
• Coxsackievirus/enterovirus IgG is common and has limited value for attributing an acute syndrome; appropriate-specimen PCR/RT-PCR is favored.
• EBV serology must be interpreted as a profile: VCA IgG plus EBNA IgG with absent VCA IgM usually indicates past infection. VCA IgM with absent EBNA IgG supports primary infection, whereas VCA IgG alone can be indeterminate.

Mechanistic and diagnostic context

• A fourfold rise in pathogen-specific IgG between acute and convalescent samples supports recent infection for babesiosis, C. pneumoniae, M. pneumoniae, and coxsackievirus. This serial change is fundamentally more informative than a one-time positive IgG.
• Direct pathogen detection addresses the central question of current infection more directly; for babesiosis, blood-smear or PCR detection confirms active disease.

Clinical implications

• Test results should be integrated with compatible symptoms, exposure history, illness timing, and pathogen-appropriate direct testing or paired serology. A positive isolated IgG result should not alone drive attribution of current symptoms or antimicrobial/antiparasitic treatment.

Bottom line

• Isolated IgG generally indicates previous immune exposure, while diagnosing active infection requires corroborating clinical evidence and appropriately selected confirmatory testing.